Watch Now

Would you like to receive special offers, product updates, and event news from 3D Systems? By clicking "Yes", you agree to receive follow-up email or phone communications from 3D Systems or our partners. You can also choose to opt out of communications at any time. Please click here to view our Privacy Policy or click here to manage your Preferences.

We invite you to watch this informative and engaging webinar. Our partner Andrew Lee, PhD, FluidForm’s head of bioprinting, presents an overview of FRESH 3D bioprinting. He shares its applications for research, repair, and replacement of human tissues.

In a discussion following the presentation, we cover the unique FRESH platform and its compatibility with soft materials as well as Allevi by 3D Systems bioprinting portfolio. Plus, we explore the future of bioprinting and how we can achieve our goals to solve today’s clinical challenges.

Watch now to discover more about:

  • The current state of bioprinting
  • FRESH 3D bioprinting as a unique platform for printing soft materials
  • Published example applications of FRESH 3D bioprinting
  • Discussion of the future of 3D bioprinting
  • Bioprinting with the Allevi by 3D Systems platform
On

About our Speaker

Andrew Lee, PhD
Head of Bioprinting and Co-Founder, FluidForm

Andrew Lee is the Head of Bioprinting and Co-Founder at FluidForm, a 3D bioprinting company looking to change the way we think about tissue engineering. He received his Ph.D. in Biomedical Engineering at Carnegie Mellon University in the Regenerative Biomaterials Group led by Dr. Adam Feinberg. His Ph.D. thesis work was focused on muscle tissue engineering, leveraging bioprinting to fabricate skeletal and cardiac tissue models with complex tissues architecture as well as physiologically relevant contractile functions. Part of his thesis work on 3D bioprinting cardiac tissues and components of the human heart was published in the journal Science. More broadly, Andrew is interested in the intersection between biomaterials, cellular biomechanics, computational design, and tissue development for the creation of functional cellular and tissue systems with composition and architectures that resemble those of native tissues. Beyond research interests, Andrew wants to see the growth of bioprinting as an easily accessible and ubiquitous technology that has scientific impact for both basic and translation research.

Andrew Lee - Fluidform 3D